Dergiler / Cyprus Journal of Medical Sciences / 2018 / Cilt: 3 - Sayı: 3

The Relationship between Climacteric Symptoms and Thiol/ Disulphide Homeostasis

Sayfa
132–136
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Especially in the early menopausal period, administering antioxidant agents as support may contribute to reducing the vasomotor symptoms of patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:BACKGROUND/AIMS The aim of this study was to examine the relationship between the serum thiol-disulfide balance and climacteric symptoms.
📊
Temel Bulgular & Veri:MATERIAL and METHODS A total of 106 women aged 42 to 78 years (53.18±7.39) participated in the study.
💡
Sonuç & Katkı:Especially in the early menopausal period, administering antioxidant agents as support may contribute to reducing the vasomotor symptoms of patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

BACKGROUND/AIMS The aim of this study was to examine the relationship between the serum thiol-disulfide balance and climacteric symptoms. MATERIAL and METHODS A total of 106 women aged 42 to 78 years (53.18±7.39) participated in the study. The patients were divided into three groups as the perimenopausal period, early postmenopausal period, and late postmenopausal period. The climacteric symptoms of patients were assessed with the Greene scale. The serum thiol/disulfide hemostasis was assessed with a new automatic method. The Mann-Whitney U test, one-way analysis of variance, and post-hoc Tukey tests were used. RESULTS Native thiol and total thiol levels start decreasing after menopause. Women in the late postmenopausal period have been observed to have significantly lower levels compared to women in the perimenopausal and early postmenopausal periods. In the late postmenopause, perimenopause, and early post menopause, native thiol was measured as 430.81±45.35, 474.64±47.06, 461.22±47.66 (p<0.05), while total thiol was 460.22±49.96, 506.74±51.74, 492.25±57.81 (p<0.05), respectively. There was a negative correlation observed between vasomotor symptoms and all thiol components only in the early menopause group. CONCLUSION When the duration of the menopause exceeds 5 years, thiol levels reduce. This variation may be considered to be related to increasing age. Especially in the early menopausal period, administering antioxidant agents as support may contribute to reducing the vasomotor symptoms of patients.

🔖

Bu Makaleye Atıf Yap

DESDİCİOĞLU, R., YILDIRIM, M., BAL, C., ŞENAT, A., KIR, E., EREL, Ö., YAVUZ, A. F. (2018). The Relationship between Climacteric Symptoms and Thiol/ Disulphide Homeostasis. Cyprus Journal of Medical Sciences, Cilt: 3 - Sayı: 3, 132–136. https://ajindex.com/articles/157612

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Ansar S, Tayef A, Ansari MA. Status of trace elements and antioxidants in premenopausal and postmenopausal phase of life: a comparative study. Int J Clin Exp Med 2015; 8: 19486-90
  2. Bonaccorsi G, Romani A, Cremonini E, Bergamini CM, Castaldini MC, Fila E Et al. Oxidative stress and menopause-related hot flashes may be independent events. Taiwan J Obstet Gynecol 2015; 54: 290-3. [CrossRef] 3. Bechlioulis A, Naka KK, Kalantaridou SN, Kaponis A, Papanikolaou O, Vezyraki P, et al. Increased vascular inflammation in early menopausal women is associated with hot flush severity. J Clin Endocrinol Metab 2012; 97: E760-4. [CrossRef] 4. Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008; 51: 1492-8. [CrossRef] 5. Sánchez-Rodríguez MA, Castrejón-Delgado L, Zacarías-Flores M, Arronte-Rosales A, Mendoza-Núñez VM. Quality of life among post-menopausal women due to oxidative stress boosted by dysthymia and anxiety. BMC Women’s Health 2017; 17: 1. [CrossRef] 6. Kumar S, Lata K, Mukjopadhyay S, Mukherjee TK. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective. Biochim Biophys Acta 2010; 1800: 1127-35. [CrossRef] 7. Sánchez-Rodríguez MA, Zacarías-Flores M, Arronte-Rosales A, Correa-Muñoz E, Mendoza-Núñez VM. Menopause as risk factor for oxidative stress. Menopause 2012; 19: 361-7. [CrossRef] 8. Lee R, Margaritis M, Channon KM, Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem 2012; 19: 2504-20. [CrossRef] 9. Ates I, Kaplan M, Yuksel M, Mese D, Alisik M, Erel Ö, et al. Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation. Endocrine 2016; 51: 47-51. [CrossRef] 10. Korkmaz V, Kurdoglu Z, Alisik M, Cetin O, Korkmaz H, Surer H, et al. Impairment of thiol-disulfide homeostasis in preeclampsia. J Matern Fetal Neonatal Med 2016; 3: 1-6. [CrossRef] 11. Bektas H, Vural G, Gumusyayla S, Deniz O, Alisik M, Erel O. Dynamic thiol-disulfide homeostasis in acute ischemic stroke patients. Acta Neurol Belg 2016; 116: 489-94. [CrossRef] 12. Korkmaz V, Kurdoglu Z, Alisik M, Turgut E, Sezgın O O, Korkmaz, H et al. Thiol/disulfide homeostasis in postmenopausal osteoporosis. J Endocrinol Invest 2017; 40: 431-5. [CrossRef] 13. Erel O, Neselioglu S. A novel and automated assay for t